tradmap

PRVA Privia Health Group, Inc.

$21.27 -0.98%

Data as of close

Healthcare · Services-Health Services

Privia Health Group, Inc. (PRVA) is a healthcare company in the Services-Health Services industry, with a market capitalization of $2.7 billion. Shares last traded at $21.27, 26.0% below their 52-week high. Over the past year the stock is down 13.1%. PRVA trades at a price-to-earnings ratio of 96.60, in line with the Services-Health Services median of 96.60. Net profit margin is 1.2%, above the peer median of 0.5%. Revenue grew 22.3% year over year.

Market Cap
$2.7B
Shares Out
127.7M
EPS (TTM)
$0.22
P/E (TTM)*
96.60
P/S Ratio
1.15
P/B Ratio
3.47
Dividend / Share
—
Dividend Yield
—
52-Week High
$28.75
52-Week Low
$17.51
Volume (venue)
78,712
Avg Vol (3m, venue)
69,509.413

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-3.97%
1M
+4.73%
3M
-10.56%
6M
-12.18%
YTD
-10.31%
1Y
-13.15%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
46.38
SMA (50)
$20.88
SMA (200)
$22.65
Price vs SMA50
+1.85%
Price vs SMA200
-6.11%
ATR (14)
$0.73

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.4B
Net Income
$28M
Gross Margin
—
Operating Margin
1.9%
Net Margin
1.2%
Return on Equity
3.6%
Return on Assets
1.9%
Current Ratio
1.62
Debt / Equity
0.83
Revenue Growth (YoY)
+22.3%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.07 2026-08-06
Q1 2026 $0.02 2026-05-07
Q4 2025 (derived) $0.08 2026-02-27
FY 2025 $0.18 2026-02-27
Q3 2025 $0.05 2025-11-06
Q2 2025 $0.02 2025-08-07

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Health Services peers

PRVA vs 13 industry peers (Services-Health Services), by market cap. Data as of close

P/E vs peers
96.60 / 96.60 med
+0% premium
P/S vs peers
1.15 / 1.42 med
-19% discount
Net margin vs peers
1.2% / 0.5% med
above median
1–13 of 13
LFSTLifestance Health Group, Inc.$5.1B100.163.203.2%-1.08%
PRVAPrivia Health Group, Inc.$2.7B96.601.151.2%-0.98%
WGSGenedx Holdings Corp.$1.9B—4.21-23.4%-7.17%
PNTGPennant Group, Inc.$1.4B43.841.292.9%-2.73%
USPHU S Physical Therapy Inc /Nv$1.3B39.391.564.0%-0.65%
INNVInnovAge Holding Corp.$1.2B—1.23-0.3%-2.94%
OMDAOmada Health, Inc.$1.1B253.973.531.4%-4.77%
ALPSAlps Group Inc$53M———-2.14%
EUDAEUDA Health Holdings Ltd$30M—4.40-40.7%-9.52%
DCGODocGo Inc.$21M—0.07-65.3%-14.63%
PIIIP3 Health Partners Inc.$13M—0.01-10.1%-7.10%
ATPCAgape ATP Corp$1M———-12.67%
PIIIWP3 Health Partners Inc.————-16.00%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.